Figure 1From: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?New colon cancers (%) during follow-up; bezafibrate vs. placebo (Fisher's exact test: one side p = 0.05; two side p = 0.07).Back to article page